Chemical materials

Inebilizumab (anti-CD19)

Inebilizumab (anti-CD19)

AL-AB170867 / 10MG
CAS No.:1299440-37-1
Add to Inquiry
Inebilizumab (anti-CD19)

Inebilizumab (anti-CD19)

AL-AB170867 / 1MG
CAS No.:1299440-37-1
Add to Inquiry
Inebilizumab (anti-CD19)

Inebilizumab (anti-CD19)

AL-AB170867 / 5MG
CAS No.:1299440-37-1
Add to Inquiry
Eculizumab (anti-Complement C5)

Eculizumab (anti-Complement C5)

AL-AB170870 / 1MG
CAS No.:219685-50-4
Add to Inquiry
Eculizumab (anti-Complement C5)

Eculizumab (anti-Complement C5)

AL-AB170870 / 5MG
CAS No.:219685-50-4
Add to Inquiry
Eculizumab (anti-Complement C5)

Eculizumab (anti-Complement C5)

AL-AB170870 / 10MG
CAS No.:219685-50-4
Add to Inquiry
Eculizumab (anti-Complement C5)

Eculizumab (anti-Complement C5)

AL-AB170870 / 100ΜG
CAS No.:219685-50-4
Add to Inquiry
Fresolimumab (anti-TGFb1)

Fresolimumab (anti-TGFb1)

AL-AB170872 / 5MG
CAS No.:948564-73-6
Add to Inquiry
Fresolimumab (anti-TGFb1)

Fresolimumab (anti-TGFb1)

AL-AB170872 / 1MG
CAS No.:948564-73-6
Add to Inquiry
Fresolimumab (anti-TGFb1)

Fresolimumab (anti-TGFb1)

AL-AB170872 / 10MG
CAS No.:948564-73-6
Add to Inquiry
Fresolimumab (anti-TGFb1)

Fresolimumab (anti-TGFb1)

AL-AB170872 / 100ΜG
CAS No.:948564-73-6
Add to Inquiry
Enfortumab (anti-NECTIN4)

Enfortumab (anti-NECTIN4)

AL-AB170877 / 5MG
CAS No.:1448664-46-7
Add to Inquiry
Enfortumab (anti-NECTIN4)

Enfortumab (anti-NECTIN4)

AL-AB170877 / 1MG
CAS No.:1448664-46-7
Add to Inquiry
Enfortumab (anti-NECTIN4)

Enfortumab (anti-NECTIN4)

AL-AB170877 / 100ΜG
CAS No.:1448664-46-7
Add to Inquiry
Enfortumab (anti-NECTIN4)

Enfortumab (anti-NECTIN4)

AL-AB170877 / 10MG
CAS No.:1448664-46-7
Add to Inquiry
Emibetuzumab (anti-MET)

Emibetuzumab (anti-MET)

AL-AB170880 / 5MG
CAS No.:1365287-97-3
Add to Inquiry
Emibetuzumab (anti-MET)

Emibetuzumab (anti-MET)

AL-AB170880 / 100ΜG
CAS No.:1365287-97-3
Add to Inquiry
Emibetuzumab (anti-MET)

Emibetuzumab (anti-MET)

AL-AB170880 / 10MG
CAS No.:1365287-97-3
Add to Inquiry
Emibetuzumab (anti-MET)

Emibetuzumab (anti-MET)

AL-AB170880 / 1MG
CAS No.:1365287-97-3
Add to Inquiry
Eldelumab (anti-CXCL10)

Eldelumab (anti-CXCL10)

AL-AB170882 / 100ΜG
CAS No.:946414-98-8
Add to Inquiry
Eldelumab (anti-CXCL10)

Eldelumab (anti-CXCL10)

AL-AB170882 / 1MG
CAS No.:946414-98-8
Add to Inquiry
Eldelumab (anti-CXCL10)

Eldelumab (anti-CXCL10)

AL-AB170882 / 10MG
CAS No.:946414-98-8
Add to Inquiry
Eldelumab (anti-CXCL10)

Eldelumab (anti-CXCL10)

AL-AB170882 / 5MG
CAS No.:946414-98-8
Add to Inquiry
Efalizumab (anti-ITGAL)

Efalizumab (anti-ITGAL)

AL-AB170884 / 10MG
CAS No.:214745-43-4
Add to Inquiry
Efalizumab (anti-ITGAL)

Efalizumab (anti-ITGAL)

AL-AB170884 / 5MG
CAS No.:214745-43-4
Add to Inquiry
Efalizumab (anti-ITGAL)

Efalizumab (anti-ITGAL)

AL-AB170884 / 1MG
CAS No.:214745-43-4
Add to Inquiry
Efalizumab (anti-ITGAL)

Efalizumab (anti-ITGAL)

AL-AB170884 / 100ΜG
CAS No.:214745-43-4
Add to Inquiry
Daxdilimab (anti-ILT7)

Daxdilimab (anti-ILT7)

AL-AB170886 / 1MG
CAS No.:2245966-28-1
Add to Inquiry
Daxdilimab (anti-ILT7)

Daxdilimab (anti-ILT7)

AL-AB170886 / 5MG
CAS No.:2245966-28-1
Add to Inquiry
Daxdilimab (anti-ILT7)

Daxdilimab (anti-ILT7)

AL-AB170886 / 10MG
CAS No.:2245966-28-1
Add to Inquiry
Daxdilimab (anti-ILT7)

Daxdilimab (anti-ILT7)

AL-AB170886 / 100ΜG
CAS No.:2245966-28-1
Add to Inquiry
Datopotamab (anti-TROP2)

Datopotamab (anti-TROP2)

AL-AB170888 / 100ΜG
CAS No.:2267989-53-5
Add to Inquiry
Datopotamab (anti-TROP2)

Datopotamab (anti-TROP2)

AL-AB170888 / 1MG
CAS No.:2267989-53-5
Add to Inquiry
Datopotamab (anti-TROP2)

Datopotamab (anti-TROP2)

AL-AB170888 / 5MG
CAS No.:2267989-53-5
Add to Inquiry
Datopotamab (anti-TROP2)

Datopotamab (anti-TROP2)

AL-AB170888 / 10MG
CAS No.:2267989-53-5
Add to Inquiry
Daclizumab (anti-IL2RA)

Daclizumab (anti-IL2RA)

AL-AB170892 / 1MG
CAS No.:152923-56-3
Add to Inquiry
Daclizumab (anti-IL2RA)

Daclizumab (anti-IL2RA)

AL-AB170892 / 100ΜG
CAS No.:152923-56-3
Add to Inquiry
Daclizumab (anti-IL2RA)

Daclizumab (anti-IL2RA)

AL-AB170892 / 10MG
CAS No.:152923-56-3
Add to Inquiry
Daclizumab (anti-IL2RA)

Daclizumab (anti-IL2RA)

AL-AB170892 / 5MG
CAS No.:152923-56-3
Add to Inquiry
Girentuximab (anti-CA9)

Girentuximab (anti-CA9)

AL-AB170927 / 10MG
CAS No.:916138-87-9
Add to Inquiry
Girentuximab (anti-CA9)

Girentuximab (anti-CA9)

AL-AB170927 / 5MG
CAS No.:916138-87-9
Add to Inquiry
Girentuximab (anti-CA9)

Girentuximab (anti-CA9)

AL-AB170927 / 1MG
CAS No.:916138-87-9
Add to Inquiry
Girentuximab (anti-CA9)

Girentuximab (anti-CA9)

AL-AB170927 / 100ΜG
CAS No.:916138-87-9
Add to Inquiry
Galcanezumab (anti-CALCA)

Galcanezumab (anti-CALCA)

AL-AB170931 / 5MG
CAS No.:1578199-75-3
Add to Inquiry
Galcanezumab (anti-CALCA)

Galcanezumab (anti-CALCA)

AL-AB170931 / 1MG
CAS No.:1578199-75-3
Add to Inquiry
Galcanezumab (anti-CALCA)

Galcanezumab (anti-CALCA)

AL-AB170931 / 100ΜG
CAS No.:1578199-75-3
Add to Inquiry
Galcanezumab (anti-CALCA)

Galcanezumab (anti-CALCA)

AL-AB170931 / 10MG
CAS No.:1578199-75-3
Add to Inquiry
Belimumab (anti-TNFSF13B)

Belimumab (anti-TNFSF13B)

AL-AB170933 / 5MG
CAS No.:356547-88-1
Add to Inquiry
Belimumab (anti-TNFSF13B)

Belimumab (anti-TNFSF13B)

AL-AB170933 / 10MG
CAS No.:356547-88-1
Add to Inquiry
Belimumab (anti-TNFSF13B)

Belimumab (anti-TNFSF13B)

AL-AB170933 / 1MG
CAS No.:356547-88-1
Add to Inquiry
LOCATIONS

Service location

Taipei, New Taipei, Keelung / Yilan / Hualien
Inquiry Cart

Your inquiry Cart total 0 items

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
Manage Cookies

Privacy Preference Center

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
View Privacy Policy

Manage Consent Settings

Necessary Cookies

Enable all
The operation of the website relies on these cookies, and you cannot disable them in the system. These cookies are usually set based on the actions you take (i.e., service requests), such as setting privacy preferences, logging in, or filling out forms. You can set your browser to block or prompt you about these cookies, but this may cause some website functions to stop working.